Memorial Hospital Research Laboratories

The Kayvan Keshari Lab

Research

Kayvan R. Keshari, PhD
Kayvan R. Keshari, PhD
Fred Lebow Chair at MSK

Professor

The goal of our research program is to improve our biochemical understanding of cancer metabolism and use metabolic changes to develop non-invasive methods for diagnosis as well as approaches to treat cancer. Our work takes advantage of multi-modality methods at all scales, with a special focus in hyperpolarized magnetic resonance, allowing us the ability to bring these approaches to the clinic.

View Lab Overview

The Kayvan Keshari Lab

Publications Highlights

Schild T, Wallisch P, Zhao Y, Wang YT, Haughton L, Chirayil R, Pierpont K, Chen K, Nunes-Violante S, Cross J, de Stanchina E, Thompson CB, Scheinberg DA, Perry JSA, Keshari KR. (2025) Metabolic engineering to facilitate anti-tumor immunity Cancer Cell. Mar 10;43(3):552-562.e9. doi: 10.1016/j.ccell.2025.02.004.

Patel S, Porcari P, Coffee E, Kim N, Berishaj M, Peyear T, Zhang G, Keshari KR. (2024) Simultaneous noninvasive quantification of redox and downstream glycolytic fluxes reveals compartmentalized brain metabolism. Science Advances Dec 20;10(51):eadr2058. doi: 10.1126/sciadv.adr2058.

Marin-Valencia I, Kocabas A, Rodriguez-Navas C, Miloushev VZ, González-Rodríguez M, Lees H, Henry KE, Vaynshteyn J, Longo V, Deh K, Eskandari R, Mamakhanyan A, Berishaj M, Keshari KR. (2024) Imaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiency Cell Metabolism Jun 4;36(6):1394-1410.e12. doi: 10.1016/j.cmet.2024.05.002

Keshari KR, Heller DA, Boltyanskiy R, Hricak H, Magaldi T, Overholtzer M. Engineering focusing on cancer. (2024) Cancer Cell Jul 8;42(7):1138-1141. doi: 10.1016/j.ccell.2024.04.013.

Pigliapochi R, Peyear T, Ruan T, Keshari KR. (2024) Hyperpolarized Nano-NMR Platform for Quantification of Mass Limited Samples. Analytical Chemistry. Jul 22:10.1021/acs.analchem.4c02378. doi: 10.1021/acs.analchem.4c02378

View All Publications

People

Kayvan R. Keshari, PhD

Kayvan R. Keshari, PhD

Fred Lebow Chair at MSK

Professor

  • Biochemist and Bioengineer Kayvan Keshari explores changes in cancer metabolism to develop advanced imaging techniques and cancer therapeutics.
  • BA, University of California, Berkeley
  • PhD, University of North Carolina Chapel Hill
[email protected]
Email Address
View physician profile
Physician profile

Members

Senior Research Technician
Ross Boltyanskiy, PhD
Assistant Director- Imaging & Bioengineering Lead
Elizabeth Coffee
Instructor, Neuro-Oncology
Engineering Specialist
Quinlan Cullen
Graduate Student
Research Technician
Vesselin Miloushev
Assistant Attending
Saket Patel
Research Scholar
Graduate Student
Roberta Pigliapochi
Senior Research Scientist
Project Coordinator
Paola Porcari
Senior Research Scientist
Thomas Ruan
Graduate Student
Nancy Santiappillai
Research Fellow
Thomas Smoot
Research Technician
Graduate Student
Guannan Zhang
Research Fellow
Graduate Student
H. Nikki Aldeborgh
Research Technician
Julio Alvarez
Research Technician
Yolanda Bryce, MD
Assistant Attending
Research Scholar
Andrew Cho
Graduate Student
Kofi Deh
Research Fellow
Lidia Dos Santos-Cunha
Research Fellow
Kristin Granlund
Research Associate
Simran Gupta
Research Technician
Research Technician
Nathaniel Kim
Research Fellow
Hannah Lees
Research Fellow
Project Coordinator
Alex Poot, PhD
Research Fellow
Tanya Schild
Research Fellow
Sui Seng Tee
Research Fellow
Steven Truong
Graduate Research Assistant

Achievements

  • 2012 Pathway Independent Award
  • 2012 Junior Fellow, International Society of Magnetic Resonance in Medicine
  • 2019 NIH Rising Stars
  • 2020 Distinguished Investigator, American Academy of Radiology and Biomedical Research
  • 2024 Fellow, World Molecular Imaging Society
  • 2025 Fellow, American Institute for Medical and Biological Engineering

Lab News & Events

Upcoming event

Publishing in Nature Biomedical Engineering

Memorial Sloan Kettering Cancer Center
Rockefeller Research Laboratories
430 East 67th Street
Room RRL-116
New York, NY 10065

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunities

Apply now

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Kayvan R. Keshari discloses the following relationships and financial interests:

  • Atish Technologies, Inc.
    Equity; Intellectual Property Rights
  • GE Healthcare
    Professional Services and Activities
  • Imaginostics, Inc.
    Equity
  • Mi2 Holdings LLC
    Equity; Professional Services and Activities (Uncompensated)
  • NVision Imaging Technologies GmbH
    Equity; Professional Services and Activities

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures